Mariner, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mariner, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,446,702
-3.5%
93,517
-2.0%
0.00%0.0%
Q2 2023$1,499,642
+99477.8%
95,462
+4.4%
0.00%0.0%
Q1 2023$1,506
+29.5%
91,418
+22.6%
0.00%0.0%
Q4 2022$1,163
-99.9%
74,555
-12.0%
0.00%0.0%
Q3 2022$1,098,000
+248.6%
84,688
+277.9%
0.00%
+300.0%
Q2 2022$315,000
-2.8%
22,410
-0.8%
0.00%0.0%
Q1 2022$324,00022,5930.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders